The announcement follows the formalization of the business relationship between Ganeden Biotech and Glanbia Nutritionals in the supply of probiotics for the Irish company’s formulations. Glanbia said in July it had chosen to work with Ganeden because of the heat resistant qualities of the GanedenBC30 strain in functional foods and beverages. Supplement application are also on the agenda.
The new announcement furthers the relationship, and allows Ganeden to capitalize on Glanbia’s distribution expertise and vast warehouse network located throughout North America.
“To become a partner of Glanbia Nutritionals is an incredible opportunity,” said Andrew Lefkowitz, Ganeden Biotech President and CEO. “Glanbia has a vast distribution base throughout the US and we are simply thrilled that GanedenBC30 is going to be readily accessible to companies looking to use our probiotic to enhance their products.”
“Ganeden’s probiotics are a great fit with our product portfolio because they meet our strict stability requirements for food and beverage applications,” said Richard Hazel, CEO of Glanbia Nutritionals (NA), Inc.
“We are pleased with the addition of GanedenBC30, which now allows us to work with applications that weren’t previously thought possible. The new distribution partnership will also benefit Glanbia Nutritionals by furthering our aim of expanding nationwide leadership in the ingredient industry,” added Hazel.